搜尋結果 "#IMbrave150"

動態

查看更多結果

Mary Grace N. Tamio

在 July 11 2021 at 08:27 PM 已編輯

Early Response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria

#atezolizumab #bevacizumab #hepatocellularcarcinoma #IMbrave150

For more information |⬇️
https://social.cn1699.com/livenewss/news/87871
0 0 0 0 0 0 0

留言

Like

分享